Holding a Bachelor’s degree in Pharmacy and a Master’s in Pharmacology, Rumaisa’s research journey began in 2013 focusing on pharmacoepidemiology and drug compliance in women with Polycystic Ovary Syndrome (PCOS). As a Ph.D. graduate in Pharmacology, her research was conducted at Central Drug Research Institute, Lucknow, India, and at the Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India. Rumaisa’s research endeavors have primarily revolved around advancing the field of drug discovery for diverse metabolic disorders while unraveling the pharmacological intricacies and interventions. Throughout her Ph.D., she concentrated on elucidating the pharmacological impacts of various polyphenols in addressing metabolic syndromes, with a specific focus on PCOS. The focal point of her recent research was an in-depth exploration of the effects of Naringenin on PCOS, revealing its affirmative influence on ovarian health.

Before joining to CTS FIU, Rumaisa served as a women Scientist Fellow at CSIR-CDRI Lucknow, India, with a comprehensive undertaking within the drug discovery process, focusing on the development of therapeutic interventions using various novel polyphenols for the treatment of endocrine disorders. With a proficiency in vitro cell culture technique, she has an extensive experience in preclinical pharmacology, particularly in animal handling, dosing administration and testing drug efficacy in small animal models.

Rumaisa has qualified UGC Junior Research Fellowship and National Eligibility test for lectureship, and is also a registered Pharmacist, at the Pharmacy council of India. Currently, her research will focus on extracellular vesicle signaling in the vasculature and their application as therapeutics.